approved EB-2 (NIW)

Postdoctoral Associate

Molecular Biology · China · 2022-04-18

Processing Time
147 days
Decision Date
2022-04-18
Location
North Carolina
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research on the mechanisms of proteins and viruses and the development of state-of-the-art extracellular vesicle engineering, visualization, and purification approaches. Her work focuses on improving therapeutics for a variety of human diseases by developing novel drug platforms and inhibitors against toxins.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research is essential for improving drug performance, reducing costs, and developing inhibitors against ricin, a Category B bioterrorism agent.

2 Well-positioned to Advance the Endeavor Met

The petitioner has 8 years of experience, 6 peer-reviewed publications, 71 citations, and has secured funding from major federal agencies like the NIH and NSF.

3 Waiver of Job Offer and Labor Certification Met

On balance, it is beneficial to the U.S. to waive the requirements because her work addresses salient national healthcare and security concerns.

Why This Petition Was Approved

The petition was approved based on the petitioner's 8 years of research experience and her record of 6 peer-reviewed journal articles (4 first-authored) with 71 citations. The case was supported by 4 expert recommendation letters and evidence of research funding from the NIH, NSF, EPA, and NCATS, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Original Contributions
Government Alignment

Similar Cases

Others

Biotechnology · China

WeGreened EB-2 (NIW) approved
Georgia 5 days 2024-03-20
The petitioner proposes to continue his research on the structural biology of important proteins in the arterivirus family and the advanced characterization of biomolecules. His work focuses on advancing computational chemistry tools for drug discovery and developing new treatments to protect the swine industry from economic losses. Additionally, he aims to investigate pathways in tumor prevention to reduce cancer treatment costs and patient financial hardship.

General Manager

Biotechnology · India

WeGreened EB-2 (NIW) approved
Florida 27 days 2023-02-14
The petitioner proposes to continue research using biotechnological principles to analyze the interaction of viruses and drug therapies to improve public health. The work specifically focuses on developing novel methods to address major global diseases and remediate health concerns such as HIV and the Zika virus.

Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
Washington 369 days 2025-02-05
The petitioner proposes to advance computational algorithms and experimental screening techniques to streamline the creation of modular, low-cost, and efficient protein therapeutics. This work focuses on improving the stability and production of drugs like antibodies and insulins to eliminate cold-chain transportation barriers and reduce healthcare costs.

Others

Pharmaceuticals · Iran

WeGreened EB-2 (NIW) approved
598 days 2025-09-08
The petitioner proposes to advance drug discovery by designing and improving in-vitro testing methodologies to enhance precision and streamline timelines in pre-clinical research. Her work focuses on creating standardized approaches for toxin assessment to reduce the reliance on animal testing and lower the high failure rates of clinical trials.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-04-18.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 147 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,814
Success Rate 53.6%
Sustained 2,046
Dismissed 1,672

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist